CPHI to Hold Fiscal Year 2019 Earnings Conference Call On Tuesday March 31, 2020 at 8:30 a.m. ET
HAIKOU CITY,China,March 13,2020 -- China Pharmaceutical Holdings Limited (NYSE American: CPHI) ("China Pharma" or "Company"),an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China,today announced that it plans to hold its fiscal year 2019 earnings conference call on Tuesday,March 31,2020 at 8:30 a.m. ET.
Listeners may access the call by dialing 1-866-519-4004 or 65-671-350-90 for international callers,Conference ID # 9565497. A replay of the call will be accessible through April 8,2020 by dialing 1-855-452-5696 or 61-281-990-299 for international callers,Conference ID # 9565497.
About China Pharma Holdings,Inc.
China Pharma Holdings,Inc. is a specialty pharmaceutical company that develops,manufactures and markets a diversified portfolio of products,focusing on conditions with high incidence and high mortality rates in China,including cardiovascular,CNS,infectious,and digestive diseases. The Company's cost-effective business model is driven by market demand and supported by new GMP-certified product lines covering the major dosage forms. In addition,the Company has a broad and expanding nationwide distribution network across all major cities and provinces in China. The Company's wholly-owned subsidiary,Hainan Helpson Medical & Biotechnology Co.,Ltd.,is located in Haikou City,Hainan Province. For more information about China Pharma Holdings,Inc.,please visit www.chinapharmaholdings.com. The Company routinely posts important information on its website.
View original content:/news-releases/cphi-to-hold-fiscal-year-2019-earnings-conference-call-on-tuesday-march-31-2020-at-830-am-et-301022807.html